[
  {
    "title": "新光药业大股东减持169万股 研发投入“吝啬”核心产品毛利率下降",
    "href": "http://stock.jrj.com.cn/2022/11/22082037156461.shtml",
    "datetime": "2022-11-22 08:20:00",
    "code": "300519"
  },
  {
    "title": "新光药业(300519.SZ)：和丰投资累计减持1.0571%股份",
    "href": "http://stock.jrj.com.cn/2022/11/21171937154614.shtml",
    "datetime": "2022-11-21 17:19:56",
    "code": "300519"
  },
  {
    "title": "新光药业2022年前三季度净利8939.67万 同比增长1.61%",
    "href": "http://stock.jrj.com.cn/2022/10/27175037090243.shtml",
    "datetime": "2022-10-27 17:50:39",
    "code": "300519"
  },
  {
    "title": "新光药业(300519.SZ)半年度净利润6080.47万元、同比增长6.65%",
    "href": "http://stock.jrj.com.cn/2022/08/22220236923330.shtml",
    "datetime": "2022-08-22 22:02:31",
    "code": "300519"
  },
  {
    "title": "新光药业(300519.SZ)：和丰投资完成减持2.08%股份 拟继续减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2022/06/28170036764795.shtml",
    "datetime": "2022-06-28 17:00:09",
    "code": "300519"
  },
  {
    "title": "新光药业(300519.SZ)：2021年年度权益分派10派6元 股权登记日5月25日",
    "href": "http://stock.jrj.com.cn/2022/05/18201536659990.shtml",
    "datetime": "2022-05-18 20:15:30",
    "code": "300519"
  },
  {
    "title": "新光药业(300519.SZ)：和丰投资减持比例再次达到1%",
    "href": "http://stock.jrj.com.cn/2022/05/05172636570703.shtml",
    "datetime": "2022-05-05 17:26:26",
    "code": "300519"
  },
  {
    "title": "新光药业2022年第一季度净利4281.91万同比增长9.85% 理财产品收益增加",
    "href": "http://stock.jrj.com.cn/2022/05/03165036544828.shtml",
    "datetime": "2022-05-03 16:50:51",
    "code": "300519"
  },
  {
    "title": "新光药业(300519.SZ)一季度净利润4281.91万元 同比增长9.85%",
    "href": "http://stock.jrj.com.cn/2022/04/26161636475765.shtml",
    "datetime": "2022-04-26 16:16:42",
    "code": "300519"
  },
  {
    "title": "新光药业2021年净利1.14亿同比增长15.46% 董事长王岳钧薪酬20.43万",
    "href": "http://stock.jrj.com.cn/2022/04/18211136387545.shtml",
    "datetime": "2022-04-18 21:11:18",
    "code": "300519"
  },
  {
    "title": "新光药业(300519.SZ)：2021年净利增15.46%至1.14亿元 拟10派6元",
    "href": "http://stock.jrj.com.cn/2022/04/18181636386125.shtml",
    "datetime": "2022-04-18 18:16:42",
    "code": "300519"
  },
  {
    "title": "新光药业2022年第一季度预计净利4093万-4483万 同比增加5%-15% 加大市场推广力度",
    "href": "http://stock.jrj.com.cn/2022/04/08185336273581.shtml",
    "datetime": "2022-04-08 18:53:03",
    "code": "300519"
  },
  {
    "title": "新光药业(300519.SZ)：一季度净利预增5%-15%",
    "href": "http://stock.jrj.com.cn/2022/04/08154936272650.shtml",
    "datetime": "2022-04-08 15:49:27",
    "code": "300519"
  },
  {
    "title": "新光药业(300519.SZ)：减持期过半 和丰投资已减持159.96万股",
    "href": "http://stock.jrj.com.cn/2022/03/28162435885280.shtml",
    "datetime": "2022-03-28 16:24:58",
    "code": "300519"
  },
  {
    "title": "【龙虎榜】新光药业3月23日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/03/23180134869985.shtml",
    "datetime": "2022-03-23 18:01:13",
    "code": "300519"
  },
  {
    "title": "中药板块大涨，新光药业领涨，中药基金LOF（501011）盘中上涨近4%",
    "href": "http://stock.jrj.com.cn/2022/03/23111234864767.shtml",
    "datetime": "2022-03-23 11:12:20",
    "code": "300519"
  },
  {
    "title": "新光药业2021年净利1.15亿同比增长15.75% 提升经营管理效率、降本增效",
    "href": "http://stock.jrj.com.cn/2022/02/25201234468012.shtml",
    "datetime": "2022-02-25 20:12:31",
    "code": "300519"
  },
  {
    "title": "新光药业2021年预计净利1.09亿-1.19亿同比增长10%-20% 经营业绩保持稳定增长",
    "href": "http://stock.jrj.com.cn/2022/01/20183334179419.shtml",
    "datetime": "2022-01-20 18:33:02",
    "code": "300519"
  },
  {
    "title": "新光药业(300519.SZ)：2021年度净利预增10%-20%",
    "href": "http://stock.jrj.com.cn/2022/01/20164934178778.shtml",
    "datetime": "2022-01-20 16:49:47",
    "code": "300519"
  },
  {
    "title": "【龙虎榜】新光药业1月6日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/06180134130265.shtml",
    "datetime": "2022-01-06 18:01:33",
    "code": "300519"
  },
  {
    "title": "【龙虎榜】新光药业1月4日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/01/04180134121771.shtml",
    "datetime": "2022-01-04 18:01:54",
    "code": "300519"
  },
  {
    "title": "新光药业(300519.SZ)：和丰投资完成减持79.06万股 拟再减持不超2%股份",
    "href": "http://stock.jrj.com.cn/2021/12/06160133973827.shtml",
    "datetime": "2021-12-06 16:01:29",
    "code": "300519"
  },
  {
    "title": "新光药业(300519.SZ)：近日收到1项发明专利证书",
    "href": "http://stock.jrj.com.cn/2021/11/02160633803508.shtml",
    "datetime": "2021-11-02 16:06:29",
    "code": "300519"
  },
  {
    "title": "新光药业(300519.SZ)：第三季度净利升6.02%至3096.23万元",
    "href": "http://stock.jrj.com.cn/2021/10/25183833748737.shtml",
    "datetime": "2021-10-25 18:38:57",
    "code": "300519"
  },
  {
    "title": "新光药业(300519.SZ)：和丰投资减持期过半 累计减持52.46万股",
    "href": "http://stock.jrj.com.cn/2021/09/07160833398625.shtml",
    "datetime": "2021-09-07 16:08:27",
    "code": "300519"
  },
  {
    "title": "新光药业2021年半年度净利5701.59万元 同比净利增加23.89%",
    "href": "http://stock.jrj.com.cn/2021/08/25190333318099.shtml",
    "datetime": "2021-08-25 19:03:47",
    "code": "300519"
  },
  {
    "title": "新光药业：暴雨灾害造成公司财产损失，部分存货不同程度受损",
    "href": "http://stock.jrj.com.cn/2021/08/19114733279087.shtml",
    "datetime": "2021-08-19 11:47:01",
    "code": "300519"
  },
  {
    "title": "新光药业(300519.SZ)：公司遭受暴雨灾害影响 部分存货不同程度受损",
    "href": "http://stock.jrj.com.cn/2021/08/18172933274522.shtml",
    "datetime": "2021-08-18 17:29:34",
    "code": "300519"
  },
  {
    "title": "新光药业：暴雨灾害中部分存货受损 不影响正常供货",
    "href": "http://stock.jrj.com.cn/2021/08/18160233273806.shtml",
    "datetime": "2021-08-18 16:02:53",
    "code": "300519"
  },
  {
    "title": "新光药业2021年上半年预计净利5292.4万-5982.72万增长15%-30% 内部管理加强",
    "href": "http://stock.jrj.com.cn/2021/07/13201433090785.shtml",
    "datetime": "2021-07-13 20:14:42",
    "code": "300519"
  },
  {
    "title": "新光药业(300519.SZ)半年度净利润预增15%-30%",
    "href": "http://stock.jrj.com.cn/2021/07/13163933089558.shtml",
    "datetime": "2021-07-13 16:39:55",
    "code": "300519"
  },
  {
    "title": "新光药业：公司目前没有生产明确可以治疗新冠肺炎的产品",
    "href": "http://stock.jrj.com.cn/2021/06/08170332894066.shtml",
    "datetime": "2021-06-08 17:03:27",
    "code": "300519"
  },
  {
    "title": "新光药业(300519)：2020年年度权益分派实施，每10股派发现金红利6.0元（含税）",
    "href": "http://stock.jrj.com.cn/2021/05/20200832789896.shtml",
    "datetime": "2021-05-20 20:08:20",
    "code": "300519"
  },
  {
    "title": "新光药业(300519.SZ)：2020年度拟10派6元 5月27日股权登记",
    "href": "http://stock.jrj.com.cn/2021/05/20200632788928.shtml",
    "datetime": "2021-05-20 20:06:12",
    "code": "300519"
  },
  {
    "title": "新光药业(300519.SZ)：和丰投资已减持3.5783%的股份 拟继续减持不超2%的股份",
    "href": "http://stock.jrj.com.cn/2021/05/18190032777395.shtml",
    "datetime": "2021-05-18 19:00:59",
    "code": "300519"
  },
  {
    "title": "新光药业：公司目前没有产品出口印度",
    "href": "http://stock.jrj.com.cn/2021/05/14191832756813.shtml",
    "datetime": "2021-05-14 19:18:27",
    "code": "300519"
  },
  {
    "title": "新光药业：公司目前拥有6种剂型52个品种 产品以中成药制剂为主",
    "href": "http://stock.jrj.com.cn/2021/05/14185532756654.shtml",
    "datetime": "2021-05-14 18:55:13",
    "code": "300519"
  },
  {
    "title": "【龙虎榜】新光药业5月13日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2021/05/13180132749372.shtml",
    "datetime": "2021-05-13 18:01:20",
    "code": "300519"
  },
  {
    "title": "新光药业2020年净利增长5.41%：董事长王岳钧薪酬20.29万",
    "href": "http://stock.jrj.com.cn/2021/04/27181132464279.shtml",
    "datetime": "2021-04-27 18:11:31",
    "code": "300519"
  },
  {
    "title": "新光药业(300519.SZ)2020年度净利润升5.41%至9897.64万元 拟10派6元",
    "href": "http://stock.jrj.com.cn/2021/04/26182432455658.shtml",
    "datetime": "2021-04-26 18:24:42",
    "code": "300519"
  },
  {
    "title": "新光药业2021年第一季度预计净利3549.42万-4368.51万 市场推广力度加大",
    "href": "http://stock.jrj.com.cn/2021/04/08183232333333.shtml",
    "datetime": "2021-04-08 18:32:31",
    "code": "300519"
  },
  {
    "title": "新光药业(300519.SZ)一季度净利润预增30%-60%",
    "href": "http://stock.jrj.com.cn/2021/04/08163932332601.shtml",
    "datetime": "2021-04-08 16:39:49",
    "code": "300519"
  },
  {
    "title": "新光药业(300519.SZ)：和丰投资已减持1.0371%的股份",
    "href": "http://stock.jrj.com.cn/2021/04/02172332271170.shtml",
    "datetime": "2021-04-02 17:23:27",
    "code": "300519"
  },
  {
    "title": "新光药业：股东和丰投资通过大宗交易减持股份不存在违规减持和超过减持计划的情形",
    "href": "http://stock.jrj.com.cn/2021/03/23153532201623.shtml",
    "datetime": "2021-03-23 15:35:22",
    "code": "300519"
  },
  {
    "title": "新光药业：拟调整使用部分募集资金新设子公司 建设现代中药研发中心建设项目",
    "href": "http://stock.jrj.com.cn/2021/03/01193532052200.shtml",
    "datetime": "2021-03-01 19:35:27",
    "code": "300519"
  },
  {
    "title": "新光药业(300519.SZ)拟使用部分募集资金在杭州市钱塘新区投设全资子公司",
    "href": "http://stock.jrj.com.cn/2021/03/01170832051007.shtml",
    "datetime": "2021-03-01 17:08:46",
    "code": "300519"
  },
  {
    "title": "新光药业2020年度净利9890.24万增长5.33% 提升经营管理效率、降本增效",
    "href": "http://stock.jrj.com.cn/2021/02/25210832027929.shtml",
    "datetime": "2021-02-25 21:08:36",
    "code": "300519"
  },
  {
    "title": "新光药业(300519.SZ)业绩快报：2020年度净利升5.33%至9890.24万元",
    "href": "http://stock.jrj.com.cn/2021/02/25161932025820.shtml",
    "datetime": "2021-02-25 16:19:29",
    "code": "300519"
  },
  {
    "title": "新光药业：公司重视省外市场拓展近年来不断加大开拓力度",
    "href": "http://stock.jrj.com.cn/2021/02/20094231996823.shtml",
    "datetime": "2021-02-20 09:42:04",
    "code": "300519"
  },
  {
    "title": "新光药业(300519.SZ)：和丰投资减持期过半 累计减持367.54万股",
    "href": "http://stock.jrj.com.cn/2021/02/18164831987086.shtml",
    "datetime": "2021-02-18 16:48:18",
    "code": "300519"
  },
  {
    "title": "新光药业2020年预计净利9390万-1亿增长0%-10% 市场开拓力度加大",
    "href": "http://stock.jrj.com.cn/2021/01/20193231730737.shtml",
    "datetime": "2021-01-20 19:32:08",
    "code": "300519"
  },
  {
    "title": "新光药业(300519.SZ)：2020年度净利预增0%-10%",
    "href": "http://stock.jrj.com.cn/2021/01/20164231729523.shtml",
    "datetime": "2021-01-20 16:42:58",
    "code": "300519"
  },
  {
    "title": "新光药业：股东和丰投资累计减持229.24万股 占公司总股本比例1.4328%",
    "href": "http://stock.jrj.com.cn/2021/01/15183131700665.shtml",
    "datetime": "2021-01-15 18:31:42",
    "code": "300519"
  },
  {
    "title": "新光药业(300519.SZ)：股东和丰投资累计减持1.4328%股份",
    "href": "http://stock.jrj.com.cn/2021/01/15172731699957.shtml",
    "datetime": "2021-01-15 17:27:45",
    "code": "300519"
  },
  {
    "title": "新光药业(300519.SZ)：“区域营销网络建设项目”延期",
    "href": "http://stock.jrj.com.cn/2020/12/31160931612745.shtml",
    "datetime": "2020-12-31 16:09:17",
    "code": "300519"
  },
  {
    "title": "新光药业2020年前三季度净利7522.44万增长8.63% 购买理财产品收益及分红款增长",
    "href": "http://stock.jrj.com.cn/2020/10/27214431144651.shtml",
    "datetime": "2020-10-27 21:44:35",
    "code": "300519"
  },
  {
    "title": "新光药业股东和丰投资减持379.73万股 套现约6498.25万元",
    "href": "http://stock.jrj.com.cn/2020/10/22222631111407.shtml",
    "datetime": "2020-10-22 22:26:02",
    "code": "300519"
  },
  {
    "title": "新光药业2020年前三季度净利7271.38万至7963.89万 公司各项业务恢复正常",
    "href": "http://stock.jrj.com.cn/2020/10/14232331054541.shtml",
    "datetime": "2020-10-14 23:23:00",
    "code": "300519"
  },
  {
    "title": "新光药业：2020年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/10/14200031053315.shtml",
    "datetime": "2020-10-14 20:00:00",
    "code": "300519"
  },
  {
    "title": "新光药业(300519.SZ)：前三季净利预增5%-15%",
    "href": "http://stock.jrj.com.cn/2020/10/14171331052446.shtml",
    "datetime": "2020-10-14 17:13:47",
    "code": "300519"
  },
  {
    "title": "新光药业2020年上半年净利4602.09万增长6.54% 营业成本减少",
    "href": "http://stock.jrj.com.cn/2020/08/25190530587292.shtml",
    "datetime": "2020-08-25 19:05:00",
    "code": "300519"
  },
  {
    "title": "新光药业2020年上半年预计净利4319.70万元–4751.67万元 各项业务逐步恢复正常",
    "href": "http://stock.jrj.com.cn/2020/07/14235230242141.shtml",
    "datetime": "2020-07-14 23:52:53",
    "code": "300519"
  },
  {
    "title": "快讯：新光药业急速拉升6.41% 主力资金净流入492.73万元(dev)",
    "href": "http://stock.jrj.com.cn/2020/06/23102129996528.shtml",
    "datetime": "2020-06-23 10:21:00",
    "code": "300519"
  },
  {
    "title": "新光药业第一季度盈利2730.32万同比减少16.17% 研发投入减少",
    "href": "http://stock.jrj.com.cn/2020/04/27185129397374.shtml",
    "datetime": "2020-04-27 18:51:18",
    "code": "300519"
  },
  {
    "title": "手握4亿元却研发上“省钱” 新光药业业绩增速难持续",
    "href": "http://stock.jrj.com.cn/2020/04/21080729335633.shtml",
    "datetime": "2020-04-21 08:07:00",
    "code": "300519"
  },
  {
    "title": "新光药业拟10派4.5元 股息率3.02%",
    "href": "http://stock.jrj.com.cn/hotstock/2020/04/20215029331790.shtml",
    "datetime": "2020-04-20 21:50:00",
    "code": "300519"
  },
  {
    "title": "新光药业：2020年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/04/10084029253700.shtml",
    "datetime": "2020-04-10 08:40:07",
    "code": "300519"
  },
  {
    "title": "新光药业2020年第一季度预计净利2605.58万元-2931.27万元 同比下降10%-20%",
    "href": "http://stock.jrj.com.cn/2020/04/09195529248874.shtml",
    "datetime": "2020-04-09 19:55:53",
    "code": "300519"
  },
  {
    "title": "新光药业：二股东和丰投资拟减持不超960万股股份",
    "href": "http://stock.jrj.com.cn/2020/04/03071529184096.shtml",
    "datetime": "2020-04-03 07:15:00",
    "code": "300519"
  },
  {
    "title": "新光药业股东和丰投资计划减持不超过6%公司股份",
    "href": "http://stock.jrj.com.cn/2020/04/02223129179909.shtml",
    "datetime": "2020-04-02 22:31:13",
    "code": "300519"
  },
  {
    "title": "上市公司晚间利空汇总：新光药业股东拟减持不超过6%股份",
    "href": "http://stock.jrj.com.cn/2020/04/02185229178253.shtml",
    "datetime": "2020-04-02 18:52:52",
    "code": "300519"
  },
  {
    "title": "新光药业股东和丰投资拟减持不超6%股份",
    "href": "http://stock.jrj.com.cn/2020/04/02175129177970.shtml",
    "datetime": "2020-04-02 17:51:59",
    "code": "300519"
  },
  {
    "title": "新光药业：股东和丰投资计划减持不超过6%公司股份",
    "href": "http://stock.jrj.com.cn/2020/04/02171729177737.shtml",
    "datetime": "2020-04-02 17:17:20",
    "code": "300519"
  },
  {
    "title": "新光药业：股东和丰投资拟减持不超6%股份",
    "href": "http://stock.jrj.com.cn/2020/04/02170829177688.shtml",
    "datetime": "2020-04-02 17:08:00",
    "code": "300519"
  },
  {
    "title": "新光药业2019年预计净利润9390万元 同比增长6.71%",
    "href": "http://stock.jrj.com.cn/2020/02/18191528849874.shtml",
    "datetime": "2020-02-18 19:15:36",
    "code": "300519"
  },
  {
    "title": "新光药业2019年度预计净利8800万元–9680万元 同比增长0%-10%",
    "href": "http://stock.jrj.com.cn/2020/01/21205228715167.shtml",
    "datetime": "2020-01-21 20:52:05",
    "code": "300519"
  },
  {
    "title": "新光药业：2019年年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2020/01/21172028713979.shtml",
    "datetime": "2020-01-21 17:20:03",
    "code": "300519"
  },
  {
    "title": "新光药业第三季度盈利2605万 同比增长5.84%",
    "href": "http://stock.jrj.com.cn/2019/10/28090728308133.shtml",
    "datetime": "2019-10-28 09:07:19",
    "code": "300519"
  },
  {
    "title": "新光药业2019年前三季度净利6624万-7286万 加大市场开拓力度",
    "href": "http://stock.jrj.com.cn/2019/10/15185328251607.shtml",
    "datetime": "2019-10-15 18:53:40",
    "code": "300519"
  },
  {
    "title": "新光药业2019年上半年净利4320万 销售价格下降",
    "href": "http://stock.jrj.com.cn/2019/08/27213128043134.shtml",
    "datetime": "2019-08-27 21:31:31",
    "code": "300519"
  },
  {
    "title": "新光药业股东和丰投资累计减持5%股份",
    "href": "http://stock.jrj.com.cn/2019/07/22212227872227.shtml",
    "datetime": "2019-07-22 21:22:22",
    "code": "300519"
  },
  {
    "title": "新光药业：股东和丰投资累计减持5%股份",
    "href": "http://stock.jrj.com.cn/2019/07/22195127872030.shtml",
    "datetime": "2019-07-22 19:51:00",
    "code": "300519"
  },
  {
    "title": "新光药业2019年上半年净利4162万–4578万 加强营销渠道优化和市场推广力度",
    "href": "http://stock.jrj.com.cn/2019/07/13122827836551.shtml",
    "datetime": "2019-07-13 12:28:10",
    "code": "300519"
  },
  {
    "title": "新光药业股东和丰投资减持164万股 套现约2796万元",
    "href": "http://stock.jrj.com.cn/2019/06/06075027670158.shtml",
    "datetime": "2019-06-06 07:50:34",
    "code": "300519"
  },
  {
    "title": "新光药业去年净利8800万元 同比下滑17% 董事长王岳钧年薪为21万元",
    "href": "http://stock.jrj.com.cn/2019/04/19074027426623.shtml",
    "datetime": "2019-04-19 07:40:28",
    "code": "300519"
  },
  {
    "title": "新光药业：2018年净利同比降17% 拟10派3元",
    "href": "http://stock.jrj.com.cn/2019/04/18185327423739.shtml",
    "datetime": "2019-04-18 18:53:00",
    "code": "300519"
  },
  {
    "title": "新光药业：2019年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2019/04/09203027355998.shtml",
    "datetime": "2019-04-09 20:30:00",
    "code": "300519"
  },
  {
    "title": "新光药业2018年净利润8797万元 每股净资产4.71元",
    "href": "http://stock.jrj.com.cn/2019/02/27093427095840.shtml",
    "datetime": "2019-02-27 09:34:29",
    "code": "300519"
  },
  {
    "title": "新光药业2018年净利最高可达9554万元 同比下降10%",
    "href": "http://stock.jrj.com.cn/2019/01/29214926998645.shtml",
    "datetime": "2019-01-29 21:49:40",
    "code": "300519"
  },
  {
    "title": "[新光药业]谨防“私募基金”骗局 那些你需要知道的投资真相",
    "href": "http://stock.jrj.com.cn/2019/01/22000026946977.shtml",
    "datetime": "2019-01-22 00:00:00",
    "code": "300519"
  },
  {
    "title": "[新光药业]《绍兴市文明行为促进条例》",
    "href": "http://stock.jrj.com.cn/2018/11/13000025339407.shtml",
    "datetime": "2018-11-13 00:00:00",
    "code": "300519"
  },
  {
    "title": "新光药业股东和丰投资拟减持不超6%股份",
    "href": "http://stock.jrj.com.cn/2018/11/06173925311299.shtml",
    "datetime": "2018-11-06 17:39:11",
    "code": "300519"
  },
  {
    "title": "新光药业：股东和丰投资拟减持不超6%股份",
    "href": "http://stock.jrj.com.cn/2018/11/06173925311281.shtml",
    "datetime": "2018-11-06 17:39:06",
    "code": "300519"
  },
  {
    "title": "新光药业：和丰投资拟减持不超6%股份",
    "href": "http://stock.jrj.com.cn/2018/11/06172325311226.shtml",
    "datetime": "2018-11-06 17:23:00",
    "code": "300519"
  },
  {
    "title": "新光药业：2018年前三季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/10/12215025197583.shtml",
    "datetime": "2018-10-12 21:50:00",
    "code": "300519"
  },
  {
    "title": "新光药业：2018年半年度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/07/12194024806993.shtml",
    "datetime": "2018-07-12 19:40:00",
    "code": "300519"
  },
  {
    "title": "新光药业：股票停牌自查情况暨复牌公告",
    "href": "http://stock.jrj.com.cn/2018/05/16214024550136.shtml",
    "datetime": "2018-05-16 21:40:00",
    "code": "300519"
  },
  {
    "title": "7个交易日6涨停 新光药业提示风险明日复牌",
    "href": "http://stock.jrj.com.cn/2018/05/16193024549729.shtml",
    "datetime": "2018-05-16 19:30:00",
    "code": "300519"
  },
  {
    "title": "新光药业完成停牌自查 17日起复牌",
    "href": "http://stock.jrj.com.cn/2018/05/16190524549647.shtml",
    "datetime": "2018-05-16 19:05:23",
    "code": "300519"
  },
  {
    "title": "新光药业7天6涨停 股东和丰投资逢高减持150万股",
    "href": "http://stock.jrj.com.cn/2018/05/11193024528716.shtml",
    "datetime": "2018-05-11 19:30:00",
    "code": "300519"
  },
  {
    "title": "新光药业：股东和丰投资减持150万股 占比0.9375%",
    "href": "http://stock.jrj.com.cn/2018/05/11185024528520.shtml",
    "datetime": "2018-05-11 18:50:12",
    "code": "300519"
  },
  {
    "title": "新光药业：股票交易异常波动暨股票停牌核查公告",
    "href": "http://stock.jrj.com.cn/2018/05/09202024517751.shtml",
    "datetime": "2018-05-09 20:20:00",
    "code": "300519"
  },
  {
    "title": "7天收获6个涨停 新光药业明日起停牌核查",
    "href": "http://stock.jrj.com.cn/2018/05/09181524517198.shtml",
    "datetime": "2018-05-09 18:15:00",
    "code": "300519"
  },
  {
    "title": "涨停复盘:市场持续缩量运行 老次新填权多只个股走妖",
    "href": "http://stock.jrj.com.cn/2018/05/09170124516833.shtml",
    "datetime": "2018-05-09 17:01:38",
    "code": "300519"
  },
  {
    "title": "资金流:次新4股高送转2股流入居前 两市净流出179亿",
    "href": "http://stock.jrj.com.cn/hotstock/2018/05/09160124516459.shtml",
    "datetime": "2018-05-09 16:01:33",
    "code": "300519"
  },
  {
    "title": "妖股新光药业再度涨停 7日6板暴涨85%",
    "href": "http://stock.jrj.com.cn/2018/05/09093224514058.shtml",
    "datetime": "2018-05-09 09:32:14",
    "code": "300519"
  },
  {
    "title": "华锋股份、永和智控、新光药业 这些妖股有同一个特征",
    "href": "http://stock.jrj.com.cn/2018/05/09065624513076.shtml",
    "datetime": "2018-05-09 06:56:38",
    "code": "300519"
  },
  {
    "title": "涨停复盘:低位次新+医药股遭市场挖掘 连板股明显增多",
    "href": "http://stock.jrj.com.cn/2018/05/08172524510725.shtml",
    "datetime": "2018-05-08 17:25:10",
    "code": "300519"
  },
  {
    "title": "新光药业：股票异动 不存在未披露信息",
    "href": "http://stock.jrj.com.cn/2018/05/08170024510627.shtml",
    "datetime": "2018-05-08 17:00:00",
    "code": "300519"
  },
  {
    "title": "医药板块持续活跃近10股涨停 新光药业6天5板领衔",
    "href": "http://stock.jrj.com.cn/2018/05/08143224509723.shtml",
    "datetime": "2018-05-08 14:32:51",
    "code": "300519"
  },
  {
    "title": "新光药业连续涨停：不存在未披露的重大事项",
    "href": "http://stock.jrj.com.cn/2018/05/03173024488117.shtml",
    "datetime": "2018-05-03 17:30:00",
    "code": "300519"
  },
  {
    "title": "医药股热情不减 新光药业3连板",
    "href": "http://stock.jrj.com.cn/2018/05/03101424485440.shtml",
    "datetime": "2018-05-03 10:14:46",
    "code": "300519"
  },
  {
    "title": "中药板块崛起 新光药业2连板",
    "href": "http://stock.jrj.com.cn/2018/05/02103424478583.shtml",
    "datetime": "2018-05-02 10:34:40",
    "code": "300519"
  },
  {
    "title": "医药股强势爆发 新光药业秒板",
    "href": "http://stock.jrj.com.cn/2018/04/27111624464092.shtml",
    "datetime": "2018-04-27 11:16:56",
    "code": "300519"
  },
  {
    "title": "新光药业2017年净利润10615.92万元 同比下降10.76%",
    "href": "http://stock.jrj.com.cn/2018/04/17101224400718.shtml",
    "datetime": "2018-04-17 10:12:00",
    "code": "300519"
  },
  {
    "title": "新光药业持股5%以上股东计划减持不超过960万股",
    "href": "http://stock.jrj.com.cn/2018/04/11175524375978.shtml",
    "datetime": "2018-04-11 17:55:00",
    "code": "300519"
  },
  {
    "title": "新光药业：股东拟减持不超6%股份",
    "href": "http://stock.jrj.com.cn/2018/04/11172524375747.shtml",
    "datetime": "2018-04-11 17:25:00",
    "code": "300519"
  },
  {
    "title": "新光药业：2018年第一季度业绩报告预告",
    "href": "http://stock.jrj.com.cn/2018/04/09202024364106.shtml",
    "datetime": "2018-04-09 20:20:01",
    "code": "300519"
  },
  {
    "title": "[新光药业]公司荣获2017年度嵊州市工业企业三十强称号",
    "href": "http://stock.jrj.com.cn/2018/02/24000024150293.shtml",
    "datetime": "2018-02-24 00:00:00",
    "code": "300519"
  },
  {
    "title": "新光药业押注单一产品 跨区域扩张前途难料？",
    "href": "http://stock.jrj.com.cn/ipo/2014/05/30152217319679.shtml",
    "datetime": "2014-05-30 15:22:25",
    "code": "300519"
  },
  {
    "title": "黄芪生脉饮收入占比超八成 新光药业募资拟再扩产一倍",
    "href": "http://stock.jrj.com.cn/ipo/2014/05/27041517290849.shtml",
    "datetime": "2014-05-27 04:15:19",
    "code": "300519"
  },
  {
    "title": "浙江新光药业：产品结构、销售区域与供应商高度集中",
    "href": "http://stock.jrj.com.cn/ipo/2014/05/26115517286466.shtml",
    "datetime": "2014-05-26 11:55:52",
    "code": "300519"
  }
]